{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:08:02Z","timestamp":1773392882844,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0109800"],"award-info":[{"award-number":["2018YFA0109800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020-WJZD198"],"award-info":[{"award-number":["2020-WJZD198"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.prp.2023.154468","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T11:27:57Z","timestamp":1681730877000},"page":"154468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Recurrent CYP2A6 gene mutation in biphasic hyalinizing psammomatous renal cell carcinoma: Additional support of three cases"],"prefix":"10.1016","volume":"245","author":[{"given":"Xiaoyan","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanglong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Chunhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6249-2747","authenticated-orcid":false,"given":"Xiaoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154468_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.anndiagpath.2012.08.007","article-title":"Biphasic alveolosquamoid renal carcinoma: a histomorphological, immunohistochemical, molecular genetic, and ultrastructural study of a distinctive morphologic variant of renal cell carcinoma","volume":"16","author":"Petersson","year":"2012","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/PAS.0000000000000639","article-title":"Biphasic squamoid alveolar renal cell carcinoma: a distinctive subtype of papillary renal cell carcinoma","volume":"40","author":"Hes","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.12688\/f1000research.8451.1","article-title":"Case Report: Multifocal biphasic squamoid alveolar renal cell carcinoma","volume":"5","author":"Lopez","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.prp.2023.154468_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/PAS.0000000000000870","article-title":"Biphasic Squamoid Alveolar Renal Cell Carcinoma: 2 Cases in a Family Supporting a Continuous Spectrum With Papillary Type I Renal Cell Carcinoma","volume":"41","author":"Chartier","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/PAS.0000000000001467","article-title":"Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC): a distinctive neoplasm associated with somatic NF2 mutations","volume":"44","author":"Argani","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/1066896921998435","article-title":"Biphasic hyalinizing psammomatous renal cell carcinoma: another provisional entity emerging from the papillary renal cell carcinoma Pandora's box","volume":"29","author":"Gopinath","year":"2021","journal-title":"Int J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101418","article-title":"The morphological spectrum of papillary renal cell carcinoma and prevalence of provisional\/emerging renal tumor entities with papillary growth","volume":"9","author":"Lobo","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2023.154468_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001846","article-title":"NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: A Comprehensive Study of 14 Cases","author":"Paintal","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humpath.2021.12.001","article-title":"Spectrum of biphasic renal cell carcinomas with hyalinized stroma and psammoma bodies associated and not associated with NF2 alteration","volume":"121","author":"Chumbalkar","year":"2021","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.humpath.2022.02.008","article-title":"Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: further support for the newly proposed entity","volume":"123","author":"Wang","year":"2022","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib11","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pin.12844","article-title":"Biphasic squamoid alveolar renal carcinoma with positive CD57 expression: A clinicopathologic study of three cases","volume":"69","author":"Zhou","year":"2019","journal-title":"Pathol. Int"},{"key":"10.1016\/j.prp.2023.154468_bib13","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/PAS.0000000000001972","article-title":"Response to: langerhans cell histiocytosis associated with renal cell carcinoma: is it an indolent phenomenon or a more ominous pathologic process?","volume":"46","author":"Agaimy","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41379-020-0645-6","article-title":"MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features","volume":"34","author":"Denize","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib15","first-page":"6200","article-title":"Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors","volume":"63","author":"Gunawan","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2023.154468_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.acthis.2012.10.009","article-title":"Clinicopathological, genetic, ultrastructural characterizations and prognostic factors of papillary renal cell carcinoma: new diagnostic and prognostic information","volume":"115","author":"Yu","year":"2013","journal-title":"Acta Histochem"},{"key":"10.1016\/j.prp.2023.154468_bib17","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0000000000001476","article-title":"Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer","volume":"44","author":"Williamson","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib18","article-title":"Renal cell carcinoma associated with Xp11.2 translocation\/transcription factor E3 gene fusion: an adult case report and literature review","volume":"48","author":"Wang","year":"2020","journal-title":"J. Int Med Res"},{"key":"10.1016\/j.prp.2023.154468_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.semdp.2015.02.003","article-title":"MiT family translocation renal cell carcinoma","volume":"32","author":"Argani","year":"2015","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib20","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","article-title":"Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.humpath.2019.07.004","article-title":"Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA\/SDHB and FH\/2SC","volume":"91","author":"Gupta","year":"2019","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib22","article-title":"Loss of Von Hippel-Lindau (VHL) Tumor Suppressor Gene Function: VHL-HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC)","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154468_bib23","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.18632\/aging.202759","article-title":"Transcriptome and lipidome profile of human mesenchymal stem cells with reduced senescence and increased trilineage differentiation ability upon drug treatment","volume":"13","author":"Chen","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.prp.2023.154468_bib24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1349-7006.2010.01793.x","article-title":"Comparison of the pharmacokinetics and pharmacodynamics of S-1 between Caucasian and East Asian patients","volume":"102","author":"Chuah","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2023.154468_bib25","first-page":"780","article-title":"Detection of cytochrome P450-2A6, -3A5 and -4B1 with real-time polymerase chain reaction in prostate tissue","volume":"63","author":"Zencir","year":"2008","journal-title":"Z. Nat. C. J. Biosci."},{"key":"10.1016\/j.prp.2023.154468_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/cts.13135","article-title":"Functional characterization of novel rare CYP2A6 variants and potential implications for clinical outcomes","volume":"15","author":"El-Boraie","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.prp.2023.154468_bib27","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/PAS.0000000000001942","article-title":"Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC) in a Child With Neurofibromatosis Type 2 Syndrome","volume":"46","author":"Argani","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154468_bib28","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/sj.bjc.6690292","article-title":"Cytochrome P450 CYP3A in human renal cell cancer","volume":"79","author":"Murray","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2023.154468_bib29","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1186\/s12885-015-1951-0","article-title":"CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma","volume":"15","author":"Mitsui","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2023.154468_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/dmdi-2012-0001","article-title":"CYP2A6: genetics, structure, regulation, and function","volume":"27","author":"Raunio","year":"2012","journal-title":"Drug Metab. Drug Interact."},{"key":"10.1016\/j.prp.2023.154468_bib31","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1158\/0008-5472.CAN-16-0446","article-title":"Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk","volume":"76","author":"Patel","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2023.154468_bib32","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1053\/j.gastro.2016.01.035","article-title":"Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population","volume":"150","author":"Sawada","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2023.154468_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10549-018-4910-z","article-title":"Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer","volume":"172","author":"Borrie","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2023.154468_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.gpb.2016.11.004","article-title":"CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients","volume":"15","author":"Yang","year":"2017","journal-title":"Genom., Proteom. Bioinforma."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823001681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823001681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:03:27Z","timestamp":1759734207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823001681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":34,"alternative-id":["S0344033823001681"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154468","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent CYP2A6 gene mutation in biphasic hyalinizing psammomatous renal cell carcinoma: Additional support of three cases","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154468"}}